Curated News:

Medical Meetings

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Radiation boost, Breast Cancer, Ductal Carcinoma In Situ, Dcis, whole breast radiation therapy radiation, WBRT

Radiation Boost Reduces Local Tumor Recurrence for DCIS Patients Following WBRT

MoranHeadshot.jpeg

A supplemental “boost” of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Cancer, Radiation Therapy, Radiation Oncology, Sbrt, Stereotactic radiation, Lung Cancer, Cancer Research

For Some Lung Cancer Patients Receiving SBRT, One and Done Approach Works Best

RadiationMedicineWebSite2012-01-1932.jpg

A new study led by Anurag Singh, MD, of Roswell Park Cancer Institute and presented at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting suggests that a single high-intensity SBRT dose can be as effective as three slightly lower doses of radiation.

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, hypofractionated radiation therapy, low-risk prostate cancer, Prostate Cancer, NRG Oncology/RTOG 0415

Hypofractionated RT Can Reduce Treatment Time by One-Third with Comparable QOL for Prostate Cancer Patients

BrunerHeadshot.jpg

For men with early stage, low-risk prostate cancer, treatment with hypofractionated radiation therapy (RT) offers comparable health-related quality of life outcomes in one-third less treatment time than conventional RT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Cervical Cancer, Endometrial Cancer, gastrointestinal and genitourinary side effects , intensity-modulated radiation therapy , imrt

Cervical and Endometrial Cancer Patients Report Fewer Side Effects and Better Quality of Life with IMRT

KloppHeadshot.jpg

Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Prostate Cancer, intermediate risk prostate cancer, Brachytherapy, External Beam Therapy, EBT

Intermediate Risk Prostate Cancer May Be Well Controlled with Brachytherapy Alone

PrestidgeHeadshot.jpg

For men with intermediate risk prostate cancer, radiation treatment with brachytherapy alone can result in similar cancer control with fewer long-term side effects, when compared to more aggressive treatment that combines brachytherapy with external beam therapy (EBT), according to research presented today at the 58th Annual Meeting the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Prostate Cancer, Radiation Therapy, quality of life in cancer , hypofractionated radiation therapy

Study: Shortened Radiation Therapy Offers Similar Quality of Life for Low-Risk Prostate Cancer Patients

Movsas_Benjamin_13C.jpg

Low-risk prostate cancer patients may be able to undergo a shortened course of radiation therapy that cuts treatment by weeks and offers comparable outcomes and quality of life results as those who undergo longer treatment courses.

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Sbrt, Elderly Patients, Stereotactic Body Radiation Therapy, non-small cell lung cancer, Nsclc, Lung Cancer

Widespread Adoption of SBRT Has Improved Survival Rates for Elderly Patients with Early Stage Lung Cancer

FarachHeadshot.jpg

Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Prostate Cancer, Radical Prostatectomy, imrt, Astro Annual Meeting, Astro, New Jersey, Rutgers University

Radiation Therapy and Radical Prostatectomy Further Explored for Initial Diagnosis of Advanced Prostate Cancer

parikh_12suit2015DVogel.jpg

A database study examining surgical removal of the prostate gland (radical prostatectomy) or a form of radiation therapy known as IMRT to treat prostate cancer that has spread to other parts of the body (metastatic) shows an association between each of these treatments and improved overall survival.

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Prostate Cancer, extremely-hypofractionated treatment, , HYPO-RT-PC trial

Extremely Hypofractionated Radiation Therapy Shows Promising Toxicity Results for Intermediate Risk Prostate Cancer Patients

WidmarkHeadshot.jpg

For men with intermediate risk prostate cancer, side effects at two years following radiation therapy (RT) were comparable for extremely-hypofractionated treatment, which was delivered in seven fractions across two and a half weeks, and conventional treatment of 39 fractions across eight weeks, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Developing Countries, RT utilization , RTU

Unmet Need for Radiation Therapy Found Among Nearly Half of Eligible Cancer Patients in Nine Developing Countries

FidarovaHeadshot.jpg

Although approximately 50 percent of cancer patients in developing countries need radiation therapy (RT) to treat their disease, up to half of these patients do not have access to it, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Lung Cancer, narrow racial gaps, National Cancer Institute

Intervention Closes Racial Gap and Improves Treatment Rates for Early Stage Lung Cancer

ManningHeadshot.jpg

Enhanced, culturally-competent communication with early stage lung cancer patients can narrow racial gaps in curative treatment completion and increase treatment rates for all races, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Stereotactic Body Radiotherapy , Sbrt, Prostate Cancer, Shorter treatment

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

MeierHeadshot.png

High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent cancer control rates, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, SRS, Stereotactic Radiosurgery, Brain Metastases

Post-Operative Stereotactic Radiosurgery a New Standard of Care for Patients with Resected Brain Metastases

BrownHeadshot.jpg

For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBRT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, reduced radiation boost, Medulloblastoma, craniospinal axis irradiation, CSI, craniospinal irradiation

Reduced Radiation Boost Volume Recommended but Craniospinal Axis Dose Remains Unchanged for Average-Risk Pediatric Medulloblastoma

MichalskiHeadshot.jpg

In the largest trial conducted for average risk (A-R) medulloblastoma, survival rates following reduced radiation therapy (RT) boost volumes were comparable to standard treatment volumes for the primary tumor site but lower doses of craniospinal axis irradiation were associated with higher event rates and worse survival, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Prostate Cancer, molecular subtypes

Three Novel Intrinsic Subtypes of Prostate Cancer Identified

SprattHeadshot.jpg

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, SRS, Stereotactic Radiosurgery, Brain Metastases

Stereotactic Radiosurgery Decreases Rate of Post-Operative Local Recurrence for Brain Metastases

MahajanHeadshot.jpg

Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rates, when compared to observation alone following surgical resection of brain metastases, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Lung Cancer, Sbrt, Stereotactic Body Radiation Therapy

Advances in Radiation Therapy Have Improved Survival Rates for Early Stage Lung Cancer Patients

BoyerHeadshot.png

A new analysis of records in the Veteran’s Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell lung cancer (NSCLC) in recent years, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Theraphy, Radiation Oncology, Cancer Research, Lung Cancer, hypofractionated radiation therapy, NSCLC Patients

Hypofractionated Radiation Therapy Can Halve Treatment Time for Poor Performance Status Lung Cancer Patients

IyengarHeadshot.png

For patients with stage II and III non-small cell lung cancer (NSCLC) unable to receive standard treatments of surgery or chemoradiation (CRT), hypofractionated radiation therapy (RT) results in similar overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times when compared to conventional RT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Science

Business

Channels:

First Practical Guidelines for Research Antibody Validation Are the Goal at Scientific Workshop Hosted by GBSI Sept 25-27

Scientific Community to Tackle Reproducibility Standards in Antibody Research

Medicine

Channels:

High Status Job Means You Are Less Likely to Respond to Treatment for Depression

An international study has found that having a high status job means that you are less likely to respond to standard treatment with medications for depression. These results, which may have implications for clinicians and their patients, employers and public policy, are presented at the ECNP Congress in Vienna*.







Chat now!